PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Feb-2024 NICE publishes guidance in England & Wales recommending Zynlonta® (loncastuximab tesirine) as an additional option for adults with relapsed or refractory diffuse large B-cell lymphoma or high-grade B-cell lymphoma Sobi
01-Feb-2024 ALMOST HALF OF PATIENTS REMAIN UNAWARE OF THE GOVERNMENT’S PHARMACY FIRST SERVICE Charac 
01-Feb-2024 Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board Lindus Health
01-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Feb-2024 CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products AccessWire
01-Feb-2024 Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 AccessWire
01-Feb-2024 New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval AccessWire
01-Feb-2024 Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer Businesswire
01-Feb-2024 Corporate Update on Clinical Evaluation of MedMira’s Products AccessWire
01-Feb-2024 AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio Newswire
01-Feb-2024 Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024 AccessWire
01-Feb-2024 AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio AccessWire
01-Feb-2024 Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO Maxion Therapeutics
01-Feb-2024 Solidsoft Reply Spearheads Ground-breaking Migration of Finland’s National Medicines Verification System Businesswire
01-Feb-2024 Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics AccessWire
01-Feb-2024 New figures reveal 13-year difference in life expectancy between a Chelsea girl and a Blackpool boy London Medical Laboratory
01-Feb-2024 Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M) Businesswire
01-Feb-2024 Arkema Completes Its 40% Increase in Global Pebax® Elastomers Production Capacity Businesswire
01-Feb-2024 Takeda Announces Chief Financial Officer Succession Businesswire
01-Feb-2024 Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit Medios AG